Skip to content
Search

Latest Stories

Britain’s drugs plan in case of no-deal Brexit

THE UK is preparing to airlift in medicines with a short shelf life if London cannot strike a Brexit deal with the EU, the government said last Thursday (23).

London has plans to ensure a continued supply of medicines from the moment Britain leaves the European Union at the end of March, health secretary Matt Hancock said in an open letter.


It comes after NHS Providers, the group representing hospitals and ambulance services in England, warned that a lack of contingency planning for a no-deal Brexit would be a risk to services. Without national planning and coordination, “there could be both stockpiles and shortages of medicines and medical devices”, said NHS Providers chief executive Chris Hopson, in a letter seen by the media.

Hancock’s letter spelled out what England’s health system needed to consider in preparation for a no-deal Brexit.

“We will ensure the UK has an additional six weeks supply of medicines in case imports

from the EU through certain routes are affected,” Hancock said. “Pharmaceutical companies

should ensure therefore they have an additional six week supply of medicines in the UK on top of their own normal stock levels.

The letter said hospitals, doctors and pharmacies and patients would not need to stockpile additional medicines, or doctors to write longer prescriptions. Britain already keeps a three month stockpile of medicines.

The country last week also outlined wider plans for managing the fallout in the “unlikely”

scenario of Brexit talks collapsing, warning that businesses faced more customs red tape

and consumers risked higher card payment charges.

Brexit minister Dominic Raab also said Britain would adopt a series of EU rules in case of a

no-deal to allow EU imports in and urged Brussels to do the same for British goods.

Raab said Britain would continue to recognise batch testing and EU certifications for medicine to avoid disruption.

More For You

Devi Shetty AI hospital platform

The Wellsoon service targets ordinary workers, with 80 per cent having never used private healthcare previously.

Getty Images

Devi Shetty’s AI powered mobile- first hospital platform aims to transform NHS care

Highlights

  • Billionaire cardiovascular surgeon's hospitals perform heart surgeries at $1,500 compared to $70,000 in America through economies of scale.
  • AI-powered mobile platform developed over 20 years by 250 engineers instantly alerts doctors to critical test results, reducing medical errors.
  • Practice Plus Group acquisition gives NHS-trained doctor gateway to treat more British patients while cutting healthcare costs.

An Indian-origin billionaire surgeon who cared for Mother Teresa and trained in the NHS has developed an AI-powered hospital system he believes can solve Britain's healthcare crisis, revealed his plans in an interview with The Telegraph.

Dr Devi Shetty, 72, founder of India's largest hospital network Narayana Health, recently acquired Practice Plus Group hospitals in the UK and is preparing to roll out a mobile-first technology platform that has revolutionised healthcare delivery across India and Kenya.

Keep ReadingShow less